Baker McKenzie advised Celsion Corporation on the deal. Celsion Corporation, an oncology drug development company, in its registered direct offering of 25,925,925 shares of common stock…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
